This signature of reduced CCL2 signaling, myeloid cell infiltration, and TAM2-polarization has previously been associated with a predominantly anti-tumor microenvironment [17], resulting in an attenuated HCC burden [19]. The gene discussed is CCL2; the disease is neoplasm.